Evoke Pharma (EVOK) Tops Q4 EPS by 7c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Jefferies Reinstates Talen Energy (TLN) at Hold